Company Overview of Biosynexus Incorporated
Biosynexus Incorporated develops and commercializes pharmaceutical products for the prevention and treatment of multidrug resistant staphylococcal infections in infants. Its products include Pagibaximab, an anti-lipoteichoic acid monoclonal antibody for use in preventing staphylococcal infections in neonates; lysostaphin, a bacterial enzyme that destroys chemical links in the cell walls of staphylococci; and nisin, a topical antibiotic cream used for treatment of skin infections. The company has a strategic collaboration with GSK Biologicals. Biosynexus Incorporated was founded in 1999 and is based in Gaithersburg, Maryland.
9298 Gaither Road
Gaithersburg, MD 20877-1440
Founded in 1999
Key Executives for Biosynexus Incorporated
Similar Private Companies By Industry
|Stemnion, Inc.||United States|
|SYMIC Biomedical, Inc.||United States|
|Juniper Medical, Inc.||United States|
|Quartet Medicine||United States|
|MPS BioPharm||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Biosynexus Incorporated, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.